Role of Extracorporeal Treatment in Barbiturate Poisoning: A Case Report
Hemal N Shah, Ashish Jain, Mohit Somani, Priyamvada Gupta, Srishti S Jain, Ravi Jain
Keywords :
Case report, Extracorporeal treatment, Extracorporeal treatment in poisoning, Intermediate hemodialysis, Severe barbiturate poisoning
Citation Information :
Shah HN, Jain A, Somani M, Gupta P, Jain SS, Jain R. Role of Extracorporeal Treatment in Barbiturate Poisoning: A Case Report. 2024; 3 (4):105-108.
Barbiturates are a class of sedative and hypnotic drugs. These are commonly used as antiepileptics and anesthetic agents now. Current usage of sedatives in India is about 1.08%, and the abuse is about 0.11%. Barbiturate overdose or poisonings can lead to severe central nervous system depression, potentially life-threatening respiratory depression, and may lead to respiratory arrest. Treatment in the majority of cases of barbiturate poisoning is artificial ventilation and other supportive therapies. Extracorporeal treatments (ECTRs) are required in only 0.1% of cases of poisoning. There is a lack of prospective intervention studies for obvious ethical reasons; however, the ECTR in poisoning (EXTRIP) workgroup recommends the use of ECTRs in severe barbiturate overdose/poisoning.
Mowry JB, Spyker DA, Cantilena LR Jr, et al. 2012 Annual Report of the American Association of poison control centers’ national poison data system (NPDS): 30th annual report. Clin Toxicol (Phila) 2013;51(10):949–1229. DOI: 10.3109/15563650.2013.863906
Mactier R, Laliberté M, Mardini J, et al. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP Workgroup. Am J Kidney Dis 2014;64(3):347–358. DOI: 10.1053/j.ajkd.2014.04.031
Curry SC, O'Connor AD, Graeme KA, et al. Goldfrank's Toxicologic Emergencies, 11th edition. McGraw Hill; 2019.
Sieghart W. Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes. Pharmacol Rev 1995;47(2):181–234. PMID: 7568326.
Rho JM, Donevan SD, Rogawski MA. Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. J Physiol 1996;497(Pt 2):509–522. DOI: 10.1113/jphysiol.1996.sp021784
Thompson SA, Whiting PJ, Wafford KA. Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br J Pharmacol 1996;117(3):521–527. DOI: 10.1111/j.1476-5381.1996.tb15221.x
Palmer BF. Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose. Am J Kidney Dis 2000;36(3):640–643. DOI: 10.1053/ajkd.2000.16207
Mohammed Ebid AHI, Abdel-Rahman HM. Pharmacokinetics of phenobarbital during certain enhanced elimination modalities to evaluate their clinical efficacy in management of drug overdose. Ther Drug Monit 2001;23(3):209–216. DOI: 10.1097/00007691-200106000-00005
Balme RH, Lloyd-Thomas HG, Shead GV. Severe barbitone poisoning treated by haemodialysis. Br Med J 1962;1(5273):231–232. DOI: 10.1136/bmj.1.5273.231
Quan DJ, Winter ME. Extracorporeal removal of phenobarbital by high-flux hemodialysis. J Appl Ther Res 1997;2:75–79.
Zawada ET, Nappi J, Done G, et al. Advances in the hemodialysis management of phenobarbital overdose. South Med J 1983;76(1):6–8. DOI: 10.1097/00007611-198301000-00003
